WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A12 MINERAL SUPPLEMENTS

This group contains mineral supplements used for treatment of mineral deficiency. All parenteral solutions of electrolytes are classified in B05B or in B05X. Magnesium carbonate used for treatment of mineral deficiency is classified in A02AA01.


A12A CALCIUM

A12AA Calcium

Plain calcium preparations, incl. bone extracts are classified in this group. Calcium acetate mainly used for the treatment of hyperphosphatemia, is classified in V03AE07.
See also B05X - I.v. solution additives.
Combinations of different calcium salts are given the following ATC code: A12AA20. Small amounts of calcium carbonate (i.e. 300 mg per tablet) are, however, allowed at each 5th level for plain calcium preparations.
Combinations of calcium and vitamin D are classified in A12AX.
The combination of calcium acetate and magnesium carbonate is classified in V03AE.
Antacids with calcium carbonate are classified in A02AC.
See also:
A11AA02 - multivitamins and calcium
A11EC - Vitamin B-complex with minerals
A11GB01 - ascorbic acid (vit C) and calcium
A11JB - Vitamins with minerals

The DDDs are based on treatment of calcium deficiency and osteoporosis.

A12AX Calcium, combinations with vitamin D and/or other drugs

This group comprises all combined calcium preparations used in the treatment of calcium deficiency conditions and osteoporosis. Many of these are combinations with vitamins, especially vitamin A and D.
Combination packages of calcium and bisphosphonates are classified in M05BB.
Combinations with fluoride are classified in A12CD.

Last updated: 2024-01-26